Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,323 recruiting studies in this area right now.
By phase
- Not applicable4,388
- Phase 2609
- Phase 1412
- Phase 3321
- Phase 4269
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury136
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease104
- Infertility94
- Renal Cell Carcinoma80
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca34
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland90
- Illinois78
Recruiting studies6,323 total
- NCT05038462Recruiting
Fetal care study for babies with slow growth
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
BarcelonaAges 18 years+ - NCT05039801RecruitingPhase 1
Study drug IACS-6274 tested for advanced solid tumors
This Phase 1 study tests the experimental drug IACS-6274, sometimes with bevacizumab and paclitaxel, in people with advanced solid tumors that have not responded to standard treatments. It aims to find the safest dose and to learn whether the treatment can shrink or control cancer for certain tumor mutation types.
Houston, TexasAges 18 years+ - NCT05040542Recruiting
Brain scans of social emotions in infants
This study uses brain testing (including MRI scanning) to better understand how young children’s brains support social emotions and communication. It may help researchers learn what brain patterns look like in typical early development.
Xiamen, FujianAges Up to 6 years - NCT05043753Recruiting
Ultrasound screening for abnormal baby growth late in pregnancy
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
Modena, ModenaAges 18–45 - NCT05048212RecruitingPhase 2
Nivolumab, ipilimumab, and cabozantinib for kidney cancer brain spread
This Phase 2 study tests how well nivolumab plus ipilimumab, along with cabozantinib, treats untreated or worsening kidney cancer that has spread to the brain. It may help shrink brain tumors and slow the disease when standard local brain treatments aren’t the right option.
Houston, TexasAges 18 years+ - NCT05049538Recruiting
Liquid blood tests to predict endometrial cancer return
This trial studies whether blood “liquid biopsies” and tumor genetic testing can help predict whether endometrial cancer will come back after treatment. Results may help doctors plan follow-up and additional care based on a person’s recurrence risk.
Houston, TexasAges 18 years+ - NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Phoenix, ArizonaAges 18 years+ - NCT05052606Recruiting
Turner syndrome patient registry study
This is a registry study that collects health information from people who have Turner syndrome. It helps researchers better understand the condition and guide future care.
Aurora, ColoradoAges Any age - NCT05056701Recruiting
Checking early care for kidney disease after pre-eclampsia
This study looks at how to predict and diagnose chronic kidney disease (long-term kidney damage) in people who had pre-eclampsia during pregnancy, including related serious conditions. It may help identify kidney problems earlier so care can start sooner.
AngersAges 18 years+ - NCT05059444Recruiting
Blood test study to watch for cancer coming back
This study looks at whether blood tests can detect signs that cancer may return after curative-intent treatment. You would have blood drawn around your usual follow-up visits for up to 5 years, and your de-identified health data would be shared with study investigators.
Birmingham, AlabamaAges 18 years+ - NCT05060783Recruiting
Liquid blood test to help detect kidney cancer
This study tests whether a “liquid biopsy” blood test can help detect kidney cancer when a CT scan looks suspicious but does not show cancer. It may help avoid unnecessary procedures or catch cancer patterns earlier, but it will depend on the type of kidney tumor and your situation.
RoskildeAges 18 years+ - NCT05063149RecruitingPhase 3
Preemie immune treatment to prevent lung infections and wheezing
This study tests whether a bacterial “lysate” medicine, given to preterm babies, can reduce respiratory (lung) infections and wheezing. It may help protect babies’ airways during the vulnerable first months after birth.
Rotterdam, South HollandAges 1 month–2 months - NCT05062707Recruiting
Study of early aging in young people during cancer treatment
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
GroningenAges 18–39 - NCT05065372RecruitingPhase 1
Metformin test with automated insulin in teens with type 1
This Phase 1 study tests how adding metformin affects blood flow in the kidneys, insulin sensitivity, and overall heart/metabolic health in young people with type 1 diabetes. It may help researchers understand whether this combo is safe and beneficial alongside automated or pump/shot insulin care.
Aurora, ColoradoAges 12–25 - NCT05067101Recruiting
Compare two bladder cancer surgeries in men
This trial compares two types of bladder surgery to see which works better for certain men with bladder cancer. It may help you and your doctors choose the safest option that controls the cancer while preserving quality of life.
Guangzhou, GuangdongAges 20 years+ - NCT05071937RecruitingPhase 2
Talazoparib plus ZEN003694 for recurrent ovarian cancer
This Phase 2 trial tests whether combining ZEN003694 with talazoparib can slow or shrink recurrent ovarian, fallopian tube, or primary peritoneal cancer. It is designed for people who have already been treated with a PARP inhibitor before, and it may help if that cancer comes back.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT05072600RecruitingPhase 2
Pembrolizumab after complete bladder cancer treatment response
This trial studies pembrolizumab (an immunotherapy) in people with muscle-invasive bladder cancer who had a combined “trimodality” treatment and then achieved a complete response. The goal is to help control the cancer after the initial treatment is finished.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05076942RecruitingPhase 2
Study of sentinel lymph nodes in vulvar cancer
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
Orange, CaliforniaAges 18 years+ - NCT05078528Recruiting
Low-cost imaging test during cervical follow-up
This study tests a low-cost imaging approach during colposcopy, for people who have abnormal cervical screening results or need follow-up after prior abnormal cells. It may help clinics detect cervical changes more easily and at lower cost.
Porto Alegre, Rio Grande do SulAges 25 years+ - NCT05079711Recruiting
Compare a vaginal yeast test for women with symptoms
This study compares how well a new vaginal yeast (Candida) test matches a standard yeast culture test. It may help clinicians choose the most accurate, convenient way to tell whether vaginal symptoms are caused by yeast.
Fort Bragg, North CarolinaAges 18 years+ - NCT05080556RecruitingPhase 2
Adaptive chemotherapy for ovarian cancer after platinum and PARP
This trial tests a personalized (adaptive) chemotherapy plan for people with certain types of ovarian/fallopian tube/peritoneal cancer who already had platinum chemotherapy and a PARP inhibitor. It’s for patients whose cancer came back after (or still responds to) prior platinum treatment and may help delay disease progression.
LondonAges 18 years+ - NCT05080946RecruitingEarly Phase 1
Aspirin with chemotherapy to improve ovarian tumor immune features
This early-phase study tests whether adding aspirin to standard neoadjuvant chemotherapy can change immune (anti-tumor) features inside ovarian, fallopian tube, or peritoneal tumors. It may help doctors better understand which patients respond and how aspirin could make treatment work better.
Tampa, FloridaAges 18 years+ - NCT05084196RecruitingPhase 3
Melatonin to help prevent kidney damage from vancomycin
This Phase 3 study tests whether melatonin can help protect the kidneys in people who are starting or continuing vancomycin, an antibiotic that can sometimes affect kidney function. If you qualify, you would take melatonin as an added prevention step while you’re on vancomycin.
New Brunswick, New JerseyAges 18–75 - NCT05085067Recruiting
Gel treatment to help prevent scar tissue after pregnancy tissue removal
This study tests whether an injected gel helps prevent scar tissue from forming again after a procedure to remove leftover pregnancy tissue inside the uterus. If you qualify, you may receive the gel as part of a randomized trial to see if it lowers the chance of re-adhesions (re-forming tissue sticking).
Beijing, Beijing MunicipalityAges 18–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,323 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,263 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.